Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Average Foreign Price For Drugs Would Be Benchmark For Seniors In Allen Bill

Executive Summary

Drug companies would be required to sell products to Medicare at "average foreign price," under a Medicare drug benefit plan introduced by Rep. Allen (D-Maine) April 4.

You may also be interested in...



House Committee Assignments: Little Shake-Up In The New Make-Up

Members of the House Energy & Commerce and Ways & Means Committees in the 108th Congress are likely to stay the course set by their predecessors regarding prescription drug issues

House Committee Assignments: Little Shake-Up In The New Make-Up

Members of the House Energy & Commerce and Ways & Means Committees in the 108th Congress are likely to stay the course set by their predecessors regarding prescription drug issues

Senate DTC Bill Is Latest Candidate For Inclusion In Bioterrorism Conference

A Senate Democratic proposal to limit direct-to-consumer advertising is the latest pharmaceutical bill whose sponsors hope to use the bioterrorism conference measure as a vehicle for enactment

UsernamePublicRestriction

Register

PS037612

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel